Partner Headlines - GSK

  1. GlaxoSmithKline Expands Its Portfolio Of Medicines In The US ...

    Benzinga
  2. Benzinga's Weekend M&A Chatter

    Benzinga
  3. Gilead Sciences Still has More Upside

    GuruFocus
  4. Johnson & Johnson Riding High On Ebola Vaccines

    GuruFocus
  5. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  6. Hot Biotech Stocks: Isis, Kite Jump On Big Deals

    IBD
  7. Isis Pharma To Develop GI Drugs With J&J

    IBD
  8. Pfizer, Home of Lipitor and Viagra, Lifts Dividend

    IBD
  9. Ebola Drug Work Continues

    IBD
  10. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD
  11. BioMarin CEO Sees Big Future For Prosensa Drug

    IBD
  12. Weekly 3-Year Low Highlights: RDS.B, GSK, WPZ, CLR

    GuruFocus
  13. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga
  14. Pfizer Spreading Its Wings Into A New Domain Of Life Sciences

    GuruFocus
  15. Merck Bets $9.5 Billion On Cubist's War On Superbugs

    IBD
  16. GlaxoSmithKline's Move A Testament That Pharma Companies Are ...

    Benzinga
  17. The Top 5 European Stocks Held During Q3

    GuruFocus
  18. BioMarin buying Prosensa

    IBD
  19. BioMarin Buying Prosensa, Backing Up Troubled Drug

    IBD
  20. Screening Pharma Stocks Amid Turnaround

    YCharts
  21. Jeff Auxier Buys Berkshire Hathaway in Third Quarter

    GuruFocus
  22. Apollo may make Glaxo offer

    IBD
  23. Irving Kahn Starts New Position In GlaxoSmithKline

    GuruFocus
  24. Irving Kahn Buys Stake in GlaxoSmithKline During Q3 2014

    GuruFocus
  25. Insys Q3 Beats Estimates, Helping Stock Rebound

    IBD
  26. Kahn Brothers' Third Quarter Numbers

    GuruFocus
  27. Ebola Vaccine Contenders

    Benzinga
  28. Stock Futures Upshift On Data; Yahoo, Broadcom, Boeing Climb

    IBD
  29. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga
  30. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  31. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga
  32. Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear

    IBD
  33. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD
  34. Action Heats Up in Ebola-Related Equities

    FoxBusiness
  35. Guru Stocks at 52-Week Lows: BHP, GSK, UTX, SAP, TEF

    GuruFocus
  36. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts
  37. Royal Bank of Scotland

    IBD
  38. Gilead's New HIV Drug Key To Long-Term Strategy

    IBD
  39. International Securities For A Diversified Income Portfolio

    GuruFocus
  40. Could European Funds Offer An Opportunity Now?

    Benzinga
  41. Widely Held Guru Stocks Trading In Europe

    GuruFocus
  42. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga
  43. Guru Stocks at 52-Week Lows: BHP, GSK, EC, VALE, ABB

    GuruFocus
  44. China Fines Glaxo For Bribes

    IBD
  45. Guru Stocks at 52-Week Lows: BHP, GSK, VOD, LYG, TEF

    GuruFocus
  46. Stock Futures Down, But Not Far; Alibaba Sets IPO Price Range

    IBD
  47. Benzinga's M&A Chatter for Wednesday August 27, 2014

    Benzinga
  48. GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) ...

    Benzinga
  49. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  50. 3 Dividend Kings From The U.K. I Love To Buy

    GuruFocus
  51. UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta ...

    Benzinga
  52. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus
  53. Intermune up on buyout buzz

    IBD
  54. You Should Consider Adding GlaxoSmithKline Based on Tremendous ...

    GuruFocus
  55. Drugmaker AstraZeneca Returns To Growth

    IBD
  56. Widely Held Guru Stocks Near 52-Week Lows

    GuruFocus
  57. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives ...

    Benzinga
  58. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga
  59. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS

    GuruFocus
  60. Glaxo, Genmab Report Positive Interim Result for Phase III Study ...

    Benzinga
  61. A Look at the Week's Top Dividend Growers

    GuruFocus
  62. Markets Little Changed Ahead Of The Federal Reserve's Policy ...

    Benzinga
  63. GlaxoSmithKline

    IBD
  64. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  65. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine ...

    Benzinga
  66. Morning Market Movers

    Benzinga
  67. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With ...

    Benzinga
  68. Highest Yielding Stocks Widely Held By The Gurus

    GuruFocus
  69. British Stocks: Sweet Spot For European Value

    YCharts
  70. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  71. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart ...

    Benzinga
  72. Advances In HIV, Hep C Treatments Could Spark Renewed Interest ...

    Benzinga
  73. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  74. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies ...

    Benzinga
  75. Major British Companies Lead Top Guru-Held UK and Ireland Stocks ...

    GuruFocus
  76. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  77. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  78. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga
  79. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  80. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  81. Can Pfizer Make Up Its Loss?

    GuruFocus
  82. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  83. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  84. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  85. #PreMarket Primer: Thursday, May 1: Fed Brushes Off Dissapointing ...

    Benzinga
  86. Glaxo hurt by Advair scandal

    IBD
  87. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
  88. Stock Futures Slip as Traders Brace for Economic Flood

    FoxBusiness
  89. Disappointing GDP Reading Weighs on Stocks

    FoxBusiness
  90. China Rule Change Further Opens Yuan To World Markets

    IBD
  91. Weekly 52-Week Highs Highlight: AV, XEL, OKE, GSK

    GuruFocus
  92. GSK, MMV Announce Commencement of Phase III Programme of Tafenoquine ...

    Benzinga
  93. These Three Pharmaceutical Companies Shake The Market With Their ...

    GuruFocus
  94. Benzinga Weekly Preview: Earnings Season Continues As Biotech ...

    Benzinga
  95. Big Pharmas Swap Specialties

    IBD
  96. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  97. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  98. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  99. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  100. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
Trading Center